These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 33122505)

  • 1. THE ARTICLE "DEMONSTRATION AND MITIGATION OF AEROSOL AND PARTICLE DISPERSION DURING MASTOIDECTOMY RELEVANT TO THE COVID-19 ERA" BY CHEN JX, ET AL. [EPUB AHEAD OF PRINT] REFERS.
    Merven M; Loock JW
    Otol Neurotol; 2021 Feb; 42(2):346-347. PubMed ID: 33122505
    [No Abstract]   [Full Text] [Related]  

  • 2. Aerosol Dispersion During Mastoidectomy and Custom Mitigation Strategies for Otologic Surgery in the COVID-19 Era.
    Chari DA; Workman AD; Chen JX; Jung DH; Abdul-Aziz D; Kozin ED; Remenschneider AK; Lee DJ; Welling DB; Bleier BS; Quesnel AM
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):67-73. PubMed ID: 32660367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration and Mitigation of Aerosol and Particle Dispersion During Mastoidectomy Relevant to the COVID-19 Era.
    Chen JX; Workman AD; Chari DA; Jung DH; Kozin ED; Lee DJ; Welling DB; Bleier BS; Quesnel AM
    Otol Neurotol; 2020 Oct; 41(9):1230-1239. PubMed ID: 32925848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Droplet and Aerosol Generation With Mastoidectomy During the COVID-19 Pandemic: Assessment of Baseline Risk and Mitigation Measures With a High-performance Cascade Impactor.
    Freiser ME; Dharmarajan H; Sri Kavya Boorgu DS; Sim ES; Corcoran TE; Jabbour N; Chi DH
    Otol Neurotol; 2021 Apr; 42(4):614-622. PubMed ID: 33710998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMPROVING BARRIER DRAPES FOR THE MITIGATION OF AEROSOL AND PARTICULATE SPREAD DURING MASTOIDECTOMY.
    Chen JX; Workman AD; Chari DA; Jung DH; Kozin E; Lee DJ; Welling DB; Bleier BS; Quesnel AM
    Otol Neurotol; 2021 Feb; 42(2):347-349. PubMed ID: 33122506
    [No Abstract]   [Full Text] [Related]  

  • 6. The challenge of performing mastoidectomy using the operating microscope with coronavirus disease 2019 personal protective equipment (PPE).
    Clamp PJ; Broomfield SJ
    J Laryngol Otol; 2020 Aug; 134(8):739-743. PubMed ID: 32718359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Consideration and prevention of the aerosol transmission of 2019 novel coronavirus].
    Yu YX; Sun L; Yao K; Lou XT; Liang X; Zhao BW; Mu QX; Du H; Zhao Y; Zhang H
    Zhonghua Yan Ke Za Zhi; 2020 Sep; 56(9):653-656. PubMed ID: 32171189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro comparison of surgical techniques in times of the SARS-CoV-2 pandemic: electrocautery generates more droplets and aerosol than laser surgery or drilling.
    Guderian DB; Loth AG; Weiß R; Diensthuber M; Stöver T; Leinung M
    Eur Arch Otorhinolaryngol; 2021 Apr; 278(4):1237-1245. PubMed ID: 32895799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airborne aerosols particles and COVID-19 transition.
    Ehsanifar M
    Environ Res; 2021 Sep; 200():111752. PubMed ID: 34302822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosol Generation and Mitigation During Methacholine Bronchoprovocation Testing: Infection Control Implications in the Era of COVID-19.
    Subat YW; Hainy ME; Torgerud KD; Sajgalik P; Guntupalli SK; Johnson BD; Chul-Ho K; Lim KG; Helgeson SA; Scanlon PD; Niven AS
    Respir Care; 2021 Dec; 66(12):1858-1865. PubMed ID: 34789516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airborne Aerosol Generation During Endonasal Procedures in the Era of COVID-19: Risks and Recommendations.
    Workman AD; Jafari A; Welling DB; Varvares MA; Gray ST; Holbrook EH; Scangas GA; Xiao R; Carter BS; Curry WT; Bleier BS
    Otolaryngol Head Neck Surg; 2020 Sep; 163(3):465-470. PubMed ID: 32452739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barrier for Particle Dispersion Control During Mastoidectomy.
    Muniz CR; Pena CFO; da Fonseca MRS; de Freitas MR
    Int Arch Otorhinolaryngol; 2021 Apr; 25(2):e296-e300. PubMed ID: 33968236
    [No Abstract]   [Full Text] [Related]  

  • 13. Two-drape closed pocket technique: minimizing aerosolization in mastoid exploration during COVID-19 pandemic.
    Das A; Mitra S; Kumar S; Sengupta A
    Eur Arch Otorhinolaryngol; 2020 Dec; 277(12):3529-3532. PubMed ID: 32914255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosol transmission of SARS-CoV-2? Evidence, prevention and control.
    Tang S; Mao Y; Jones RM; Tan Q; Ji JS; Li N; Shen J; Lv Y; Pan L; Ding P; Wang X; Wang Y; MacIntyre CR; Shi X
    Environ Int; 2020 Nov; 144():106039. PubMed ID: 32822927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reply to Philip
    Echternach M; Westphalen C; Köberlein MC; Gantner S; Peters G; Benthaus T; Jakubaß B; Kuranova L; Döllinger M; Kniesburges S
    Am J Respir Crit Care Med; 2021 Apr; 203(8):1042-1043. PubMed ID: 33529548
    [No Abstract]   [Full Text] [Related]  

  • 16. The single-dose J&J vaccine had 67% efficacy against moderate to severe-critical COVID-19 at ≥14 d.
    Sacks HS
    Ann Intern Med; 2021 Jul; 174(7):JC75. PubMed ID: 34224270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of aerosol production and aerosol dispersion during otologic surgery.
    Gomez Serrano M; Santiago-Saez A; Moreno Rodriguez R; Lopez Salcedo A; Poch Perez-Botija A; Aragones Sanzen-Baker W; García Martín AF; García García JA; Iglesias Moreno MC
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3363-3369. PubMed ID: 34480224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRIORITY risk model predicted critical outcomes in patients hospitalized with COVID-19.
    Boreskie P; Lang E
    Ann Intern Med; 2021 Dec; 174(12):JC143. PubMed ID: 34871045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of Particle Size and Viability of SARS-CoV-2 Aerosols from a Range of Nebuliser Types Using a Novel Sampling Technique.
    Paton S; Clark S; Spencer A; Garratt I; Dinesh I; Thompson KA; Bennett A; Pottage T
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In South Africa, a 2-dose Oxford/AZ vaccine did not prevent mild to moderate COVID-19 (cases mainly B.1.351 variant).
    Irfan N; Chagla Z
    Ann Intern Med; 2021 May; 174(5):JC50. PubMed ID: 33939483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.